🇫🇷
France · FR · FR:67522379
LEVOSIMENDAN KABI 2,5 mg/mL, solution à diluer pour perfusion
ATC C01CX08
Last synced from Base de données publique des médicaments — BDPM (France) on
Identification
ManufacturerFRESENIUS KABI FRANCE
CountryFR (France)
ATC codeC01CX08
Dispensing—
ReimbursedNo
SourceBase de données publique des médicaments — BDPM (France)
Last synced6/3/2026
Packs · 1
- cip1334009550865811 flacon en verre de 5 mL
Annotations
No annotations yet.
Raw payload (JSON)
{
"cis": "67522379",
"date_amm": "2022-01-03",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"statut_amm": "Autorisation active",
"statut_bdm": "Warning disponibilité",
"forme_pharmaceutique": "solution à diluer pour perfusion",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Non commercialisée",
"surveillance_renforcee": "Non"
}Related drugs
Other records sharing ATC code C01CX08.
- DKLevosimendan "Amdipharm"Amdipharm Limited
- DKLevosimendan "Bioglan"Bioglan AB
- DKLevosimendan "Carinopharm"Carinopharm GmbH
- DKLevosimendan "EQL Pharma"EQL Pharma AB
- DKLevosimendan "Farmak"Farmak International Sp. z o.o.
- DKLevosimendan "Fresenius Kabi"Fresenius Kabi AB
- DKLevosimendan "Stada"STADA Arzneimittel AG
- DKLevosimendan "Tillomed"Tillomed Pharma GmbH
Access this data programmatically
Query LEVOSIMENDAN KABI 2,5 mg/mL, solution à diluer pour perfusion and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.